Pharma company Supriya Lifescience Ltd on Monday (December 9) announced it has crossed two milestones, which it says will ...
Supriya Lifesciences advanced 1.16% to Rs 783.10 after the company received approval from Brazil's health authority, ANVISA (Agcia Nacional de Vigilcia Sanitia), for Esketamine Hydrochloride.